•   
  •   
  •   

Health & FitExperimental drug delays type 1 diabetes onset in mid-stage trial

16:45  10 june  2019
16:45  10 june  2019 Source:   reuters.com

A New DNA Test Helps You Assess Your Diabetes Risk

A New DNA Test Helps You Assess Your Diabetes Risk Here's why you probably don't need it.

In people at high risk for type 1 diabetes , 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more. The trial was financed by the National Institutes of Health and the Juvenile Diabetes Research Foundation. The findings were reported at a

the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid - stage study presented Sunday. The 76 study participants, who ranged in age from 8 to 49, faced a high risk of type 1 diabetes in part because their relatives had the autoimmune

Experimental drug delays type 1 diabetes onset in mid-stage trial© Fertnig/Getty Images (Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday.

The 76 study participants, who ranged in age from 8 to 49, faced a high risk of type 1 diabetes in part because their relatives had the autoimmune disease, which kills the beta cells in the pancreas that make and release insulin. Also, the volunteers all had tests showing diabetes-related autoantibodies that attack the pancreas, plus unhealthy blood sugar levels.

12 Reasons Why You Aren't Waking Up Feeling Refreshed in the Morning

12 Reasons Why You Aren't Waking Up Feeling Refreshed in the Morning Here are the 12 things that could explain your sluggishness. Lifestyle Factors That Explain Why You're Always Tired Chances are, solving the reason you're tired all the time is easy to control, and takes just a few simple changes to your day-to-day habits. You're sleeping on an old mattress or pillow The National Sleep Foundation recommends replacing your mattress every nine to 10 years, and pillows once a year. Your bedroom is too warm A hot bedroom can make it difficult to fall asleep (and stay asleep). The NSF has settled on a magic number for perfect rest: 65 degrees Fahrenheit.

(Reuters Health) – In people at high risk for type 1 diabetes , 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid - stage study presented Sunday. The 76 study participants, who ranged in age from 8 to 49, faced

The trial was financed by the National Institutes of Health and the Juvenile Diabetes Research Foundation. The findings were reported at a meeting of Many new drugs cost more than 0,000 per year. If teplizumab were to delay development of type 1 diabetes for a year or so, said Herold

Among the 44 volunteers randomly assigned to receive the drug, 19, or 43%, developed diabetes, with the disease appearing within 48.4 months in half of them.

By comparison, among the 32 people who received a placebo, 23, or 72%, developed diabetes, with half the patients developing it within 24.4 months.

When the study was stopped, the percentage of diabetes-free participants was twice as high in the teplizumab group (57%) as in the placebo group (28%).

The chief side effects were temporarily low levels of lymphocytes - a type of white blood cell - and rash.

Provention Bio Inc is developing the drug. The trial was financed by the National Institutes of Health and the Juvenile Diabetes Research Foundation. The findings were reported at a meeting of the American Diabetes Association in San Francisco and in The New England Journal of Medicine.

Hormones Can Cause Belly Fat - Here's What You Can Do to Lose It, According to 2 Experts

Hormones Can Cause Belly Fat - Here's What You Can Do to Lose It, According to 2 Experts Belly fat happens especially as our metabolism slows down with age, and it largely has to do with genetics. Here's what you can do about it.

A new drug may delay the onset of insulin-dependent Type 1 diabetes in those who are at high risk for the autoimmune disease, according to the results of a trial published in New England Journal of Medicine. “This is the first time we have showed that immune therapy can delay progression to Type

A placebo-controlled, double-blind trial finds that teplizumab delays the onset of type 1 diabetes by Males are more likely to develop type 1 diabetes than females, and having a family history of the Geography also seems to play a role in type 1 diabetes risk. For instance, Sweden, Finland, Norway

"After repeated failures, this is the first time anyone's been able to delay the onset of type 1 diabetes," chief author Dr. Kevan Herold of Yale University in New Haven, Connecticut told Reuters Health by phone. "The rate of development of diabetes was reduced by half."

Dr. Clifford Rosen of the Maine Medical Center Research Institute and Journal deputy editor Dr. Julie Ingelfinger wrote in an editorial, "We can finally say that there has been substantial progress in modulating the early course of type 1 diabetes."

Additional studies will be required before regulatory agencies approve the drug.

About 1.25 million people in the U.S. have type 1 diabetes, with nearly 18,000 new cases diagnosed annually in people under age 20, the American Diabetes Association says.

Teplizumab works by modifying the white blood cells from the immune system that kill insulin-producing cells in the pancreas.

We rank the best & worst airports for flight delays

We rank the best & worst airports for flight delays The best & worst airports ranked

Staging Presymptomatic Type 1 Diabetes : A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. After onset of islet autoimmunity, the disease progresses through a presymptomatic stage identified by markers of autoimmunity and glucose intolerance, or

In people with type 1 diabetes , the onset of symptoms can be very sudden, while in type 2 diabetes , they tend to come about more gradually, and sometimes there are no signs at all. Symptoms sometimes occur after a viral illness. In some cases, a person may reach the point of diabetic ketoacidosis (DKA)

The drug's greatest impact seemed to be in the first year after treatment, when only 7% developed type 1 diabetes, compared with 44% who received placebo.

Another round of therapy might further delay diabetes development and "that's what we're hoping to do," said Herold.

He said there would be reluctance to give the drug long-term for fear it might throttle back the immune system too much.

"It's been felt that to have a really effective treatment, you need a drug you give for a short period of time so people are not chronically immunosuppressed," he said.

Many new drugs cost more than $100,000 per year. If teplizumab were to delay development of type 1 diabetes for a year or so, said Herold, people might think that's worth it.

"You have to talk to someone who has diabetes," he said. "I think most people would tell you a day without diabetes is terrific because the disease is a 24/7 disease. You can't sleep, you can't eat, you can't walk without considering it. And three quarters of the people here are children. We're talking about a critical time in their development."

Type 1 diabetes typically takes more than a decade off a person's life.

SOURCE: https://bit.ly/2K474eE The New England Journal of Medicine, online June 9, 2019

Warning signs of diabetes you shouldn’t ignore (Eat This! Not That!)

Experimental drug delays type 1 diabetes onset in mid-stage trial
Read More

As the price of insulin skyrockets, people with diabetes are switch to affordable insulin, and it's causing deadly consequences.
Unlike medicines like over-the-counter pain medication ibuprofen, taking one brand of insulin is completely different from another. For people living with diabetes, getting the proper dose of insulin at the right time is crucial for glucose at the right level. "We can't make a uniform recommendation because every patient had a different blood-glucose profile, but the considerations are making sure you understand what the new type of insulin is replacing, how to convert the dose, and when to take it," Mathioudakis told INSIDER.

Topical videos:

usr: 3
This is interesting!